Epidarex Capital is a leading transatlantic venture capital firm that invests in early-stage, high growth life science opportunities in under-ventured markets.  Epidarex funds ground-breaking research, often building companies from scratch, to address large unmet medical needs with solutions that provide significant benefits to patients.

Venture Capital

Epidarex Capital

Managing Partners

Kyparissia Sirinakis

A. Sinclair Dunlop

Epidarex Capital's CEO and Executive Team includes Amanda Crook.

CEO and Executive Team

About

Other teams at Epidarex Capital

Leadership Team

Board of Directors